Story perspectives

Medtronic Beats Earnings Estimates, Raises Fiscal 2027 Outlook

9/1/2026

Summary

Story summary

Medtronic reported first-quarter fiscal 2027 adjusted earnings of $1.45 per share, beating the $1.39 consensus.
The company posted quarterly sales of $9.756 billion, topping the $9.545 billion estimate by 2.21%.
Cardiovascular revenue rose 19.5% to $3.93 billion, driving overall sales growth.
Medtronic lifted its fiscal 2027 adjusted earnings outlook to $5.94-$6.00 per share.
It announced a $700 million investment in Cornerstone Robotics and rights to distribute its Sentire system abroad.

1 of 1

Story summary

Medtronic reported first-quarter fiscal 2027 adjusted earnings of $1.45 per share, beating the $1.39 consensus.
The company posted quarterly sales of $9.756 billion, topping the $9.545 billion estimate by 2.21%.
Cardiovascular revenue rose 19.5% to $3.93 billion, driving overall sales growth.
Medtronic lifted its fiscal 2027 adjusted earnings outlook to $5.94-$6.00 per share.
It announced a $700 million investment in Cornerstone Robotics and rights to distribute its Sentire system abroad.